Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
Authors:
- Per Ole IversenPIPer Ole Iversen
- Finn WisløffFWFinn Wisløff
- Nina GulbrandsenNGNina Gulbrandsen
- 31 August 2010
- journal article
- clinical trial
- Published by Elsevier in Clinical Nutrition
- Vol. 29 (4) , 488-491
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Multiple myelomaThe Lancet, 2009
- Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemiaLeukemia & Lymphoma, 2008
- Guidelines on the diagnosis and management of multiple myeloma 2005British Journal of Haematology, 2006
- Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesEuropean Journal of Haematology, 2004
- Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantationSupportive Care in Cancer, 2003
- Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell SupportMedical Oncology, 2001
- Thyroid hormones induce hemopoietic pluripotent stem cell differentiation toward erythropoiesis through the production of pluripoietin-like factorsExperimental Cell Research, 1990